Oct 8 (Reuters) - Bausch Health Companies Inc BHC.TO :
* BAUSCH HEALTH'S BRYHALI™(HALOBETASOL PROPIONATE) LOTION, 0.01%, RECEIVES TENTATIVE FDA APPROVAL FOR PLAQUE PSORIASIS IN ADULTS
* BAUSCH HEALTH COMPANIES INC - PLANS TO LAUNCH BRYHALI LOTION IN NOVEMBER 2018 UPON FINAL FDA APPROVAL